EliChip - ELISA-to-Field Diagnostic Platform

EliChip: ELISA-Grade Results, Anywhere

EliChip is a microfluidic immunodiagnostic platform developed by Trustech Diagnostics that delivers quantitative, ELISA-grade results outside the centralized laboratory. From a 20 µL sample, it produces digital quantitative output in minutes, without a laboratory, without specialized personnel, and without cold chain constraints. Auralis Biotech acts as commercial partner for EliChip, supporting partner identification, strategic partners matchmaking, and market access through the EliChip Early Adopter Program.

EliChip Features

  • Multi-sample

    Throughput. Multiple samples processed in a single run.

  • TRL-7

    Technology Rediness level.

  • Multi-Chemistry

    Adaptable to multi-chemistry, such as Immunoassay and Griess reaction.

  • 20 µL

    Sample input. vs 100 to 200 µL standard ELISA.

  • pg/mL

    Sensitivity. ELISA-grade accuracy in validated platform use cases.

  • less than 1h

    Time to result. Field-deployable, near the point of operational need.
Get more information

Same Science. Smarter Format.

Standard ELISA delivers quantitative pg/mL-class results but requires a centralized laboratory, 100 to 200 µL of sample, and up to 24 hours of turnaround. Lateral flow is fast but qualitative only. LAMP and PCR cannot detect proteins or toxins. EliChip fills the gap: quantitative, portable, field-deployable, and compatible with proteins, toxins, and small molecules across complex matrices including blood, milk, serum, grain, and synovial fluid.

See validated applications

Tested across multiple sectors

  • Clinical and Research

    IL-6, TNF-alpha, NGF, MMP-2, MMP-9 via immunochemistry. Nitric oxide via Griess reaction.

    Publication 

  • Agrifood

    Aflatoxin M1 and B1, Ochratoxin A, Gluten and Lysozyme.

  • Veterinary

    BVD, Leishmania.

  • Plant Health

    Xylella fastidiosa and Flavescence doree testing in collaboration with Agritest.

Join the Early Adopter Program

The program is limited to 10 participants globally. Convert your existing ELISA into a field-deployable microfluidic format, commercialize under your own brand, and secure 12 months of assay-specific market exclusivity.

Request feasibility discussionDownload the EliChip flyer